Solagran have been told by the Russian Ministry of Health that Ropren will be Approved during this month. Europe will be next to come online, as, as you say, easier to get Approval than Western countries. I believe they would also have more respect for Russian science/previous trials.
For Western countries such as USA/Australia etc, Solagran have stated that they have already begun initial talks with a Big Pharma for worldwide liscence. This company would look after costs of Phase111 trials, Approval process' etc. This deal will be Massive IMO. Solagran have stated that they will wait until Ropren is Approved in Russia before entering more discussions(ie better bargaining/deal position).
Ropren will be available, as Spicer says, under a "3-month personal supply" rule. Probably looking at around US$4,000 for it.
Bioeffective A is already under FDA review.
Do your own research and I think you'll find alot of upside in this little company. Great management and products. Huge targeted markets-liver, dementia, depression, addiction to name a few. Contribs,options, BPO cash,Bio A and B income all should more than tide SLA over until the real income starts in October/November
Cheers and good luck
BB
SLA Price at posting:
0.0¢ Sentiment: Buy Disclosure: Not Held
